| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 02/27/2008 | CN101130077A Remedy for spinal injury containing interleukin-6 antagonist |
| 02/27/2008 | CN101130043A Oral liquid of eaglewood for warming medium |
| 02/27/2008 | CN101130041A Oral liquid for refreshing spirit |
| 02/27/2008 | CN101130018A Pill of magnolia officinalis for lowering the adverse rise of energy |
| 02/27/2008 | CN101129960A Glutinous rehmannia soup against fatigue |
| 02/27/2008 | CN101129826A Health pillow with Chinese medicine |
| 02/27/2008 | CN101129758A Xiongsu powder |
| 02/27/2008 | CN101129691A Hernia soup of Chinese angelica |
| 02/27/2008 | CN101129684A Medicament for treating children's hernia |
| 02/27/2008 | CN101129610A Vitality raising pill of glutinous rehmannia |
| 02/27/2008 | CN101129571A Oral liquid of prunella spike |
| 02/27/2008 | CN101129471A Quality control method of south schizandrol extract oral solid formulated product |
| 02/27/2008 | CN101129467A Traditional Chinese medicine for treating paraplegia |
| 02/27/2008 | CN101129435A Reddish blue flower wine |
| 02/27/2008 | CN101129349A Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them |
| 02/27/2008 | CN101129151A Multifunctional healthy tea |
| 02/27/2008 | CN100371714C Methods and compositions for treatment of central nervous system disorders |
| 02/27/2008 | CN100371442C Ligand/receptor specificity exchangers that redirect antibodies to receptors on pathogen |
| 02/27/2008 | CN100371323C Cyanopyrrolidine derivatives |
| 02/27/2008 | CN100370990C Controlled release galantamine composition |
| 02/27/2008 | CN100370987C Tartrate salt of 5,8,14-triazatetracyclo [10,3,1,02,11.04,9]-hexzdeca-2(11),3,5,7,9-pentaene |
| 02/27/2008 | CN100370914C Health-care tea containing antifatigue anti senility Chinese herbal medicine |
| 02/27/2008 | CN100370909C Method for preparing kidney-warming face-beautifying milk powder with micron pine pollen, deer placenta powder, glossy privet fruit powder, white fungus powder and safflower powder |
| 02/26/2008 | US7335776 Remedies for depression containing EP1 antagonist as the active ingredient |
| 02/26/2008 | US7335774 Quinolinone derivatives |
| 02/26/2008 | US7335773 induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; exhibit antiviral and antitumor properties |
| 02/26/2008 | US7335765 Nucleoside and oligonucleotide analogues |
| 02/26/2008 | US7335734 Protein polymer having unfold activity on higher-order structure of protein |
| 02/26/2008 | US7335727 fusion inhibitor; high stability and high valence; higher efficacy, and lower administration dosage, and thereby lower toxicity. |
| 02/26/2008 | US7335722 For use in pharmaceuticals, food additivs |
| 02/26/2008 | US7335681 Inhibit glucosyl ceramide (GlcCer) formation by inhibiting the enzyme GlcCer synthase; Gaucher's disease, Tay Sachs disease, Fabry's disease. Sandhoff disease or GM1 gangliosidosis |
| 02/26/2008 | US7335680 Preterm labor, dysmenorrhea, asthma, hypertension, fertility disorder, sexual dysfunction, undesired blood clotting, bone disorders, preeclampsia or eclampsia, or an eosinophil disorder; use with phosphodiesterase inhibitors; e.g. 7-[(2R,3R)-3-Chloro-1-(4-hydroxynonyl)-pyrrolidin-2-yl]-hept-5-enoic acid |
| 02/26/2008 | US7335679 Wortmannin analogs and methods of using same |
| 02/26/2008 | US7335677 Inhibitors of dipeptidyl peptidase IV |
| 02/26/2008 | US7335673 2,3-Diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage |
| 02/26/2008 | US7335663 Heteroaryl compounds which inhibit leukocyte adhesion mediated by α4 integrins |
| 02/26/2008 | US7335659 Substituted 10-aryl-11H-benzo[b]fluorenes and 7-aryl-5, 6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors |
| 02/26/2008 | US7335655 Treating asthma with e.g. 2-(3-methoxyphenyl)-N-[5-(2,6-dioxo-1,3-dipropyl-2,3,6,9-tetrahydro-1H-purin-8-yl)-1-methyl-1H-pyrazol-3-yl]acetamide; potent, yet selective modulators of adenosine receptors |
| 02/26/2008 | US7335654 Phosphodiesterase 4 inhibitors |
| 02/26/2008 | US7335649 3-{N'-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2-hydroxy-3'-(tetrazol-5-yl)biphenyl for treatment of thrombocytopenia; colony stimulating factors |
| 02/26/2008 | US7335647 Drugs for liver diseases |
| 02/26/2008 | US7335645 For prophylaxis or treatment of skin or mucosa, autoimmune diseases and inflammation |
| 02/26/2008 | US7335499 tRNA synthetase |
| 02/26/2008 | US7335371 Combinations for the treatment of inflammatory disorders |
| 02/26/2008 | CA2430592C New pharmaceutical compositions based on anticholinergics and dopamine agonists |
| 02/26/2008 | CA2363124C Use of aromatic polycyclic compounds as activators of ppars-type receptors in a cosmetic or pharmaceutical composition |
| 02/26/2008 | CA2300910C Phosphono-carboxylate compounds for treating amyloidosis |
| 02/26/2008 | CA2078544C Method and compositions for treating injury |
| 02/21/2008 | WO2008021959A2 Influenza hemagglutinin and neuraminidase variants |
| 02/21/2008 | WO2008021550A2 Thiol-based agents for reducing toxicities associated with medical procedures employing radiographic contrast agents |
| 02/21/2008 | WO2008021375A2 Modulators of muscarinic receptors |
| 02/21/2008 | WO2008020651A1 P2x4 receptor antagonist |
| 02/21/2008 | WO2008020625A1 Dibenzoylmethane compound and pharmaceutical composition comprising the compound as active ingredient |
| 02/21/2008 | WO2008020622A1 NOVEL THIENO[2,3-d]PYRIMIDINE COMPOUND |
| 02/21/2008 | WO2008020586A1 Diagnosis and treatment of cancer using anti-desmoglein-3 antibody |
| 02/21/2008 | WO2008020495A1 Novel inhibitor |
| 02/21/2008 | WO2008020490A1 Artocarpine derivative or artocarpine-like compound, and hair growth/restoration composition, skin-whitening cosmetic composition, pharmaceutical as anti-cancer, antiphlogistic/analgesic, antipyretic or antiallergic agent and pharmaceutical for treatment of pigmented skin lesion each comprising the same |
| 02/21/2008 | WO2008020040A2 2,5-dihydroxybenzene compounds for the treatment of fibrosis |
| 02/21/2008 | WO2008019594A1 Agmatine sulfate dihydrate and its medicinal use |
| 02/21/2008 | WO2007149451A3 Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors |
| 02/21/2008 | WO2007140410A9 Low-density lipoprotein receptor 6 (lrp6) as a mammary stem cell marker and related methods |
| 02/21/2008 | WO2007110243A8 Medicament, cosmetic or food product comprising an indol compound, the use thereof and the method of isolation thereof from sauerkraut |
| 02/21/2008 | WO2007049796A3 Resveratrol and/or grape leaf extract as i. a. endurance improver, anti-aging agent, muscle strength improver |
| 02/21/2008 | US20080045606 Production and Use of Monoglycerides |
| 02/21/2008 | US20080045585 Macrocyclic Compounds And Methods Of Making And Using The Same |
| 02/21/2008 | US20080045575 Delivery of H2 Antagonists |
| 02/21/2008 | US20080045572 Pharmaceutical Composition Comprising Roflumilast or the N-Oxide of Roflumilast |
| 02/21/2008 | US20080045548 Pharmaceutical Compositions |
| 02/21/2008 | US20080045531 Anti-inflammatory medicaments |
| 02/21/2008 | US20080045528 6-o-substituted benzoxazole and benzothiazole compounds and methods of inhibiting csf-1r signaling |
| 02/21/2008 | US20080045524 Selective NPY (Y5) antagonists |
| 02/21/2008 | US20080045522 Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells |
| 02/21/2008 | US20080045497 Substituted aniline derivatives |
| 02/21/2008 | US20080045489 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 02/21/2008 | US20080045480 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 02/21/2008 | US20080045474 Method for treatment of invasive cells |
| 02/21/2008 | US20080045473 Compositions and methods for oligonucleotide formulations |
| 02/21/2008 | US20080045470 Ceramides and Apoptosis-Signaling Ligand |
| 02/21/2008 | US20080045469 Compositions and Methods for Inhibiting Angiogenesis |
| 02/21/2008 | US20080045464 Natural Sweetener |
| 02/21/2008 | US20080045463 Methods For Lowering Hif-1 Mediated Gene Expression |
| 02/21/2008 | US20080045458 synthetic polypeptides; isolated and purified from the submaxiliary saliva glands of shrews of the species Blarina as a paralytic agent for reducing wrinkles; inhibits calcium uptake; encoded from nucleic acid; analgesic or insecticide |
| 02/21/2008 | US20080045456 Use of wild type angiogenin |
| 02/21/2008 | US20080045454 Polynucleotide encoding a TRIM-cyp polypeptide, compositions thereof, and methods of using same |
| 02/21/2008 | US20080045452 Regulation of Cytokine Synthesis and Release |
| 02/21/2008 | US20080045451 Novel thymidylate synthase mutants |
| 02/21/2008 | US20080044806 diagnostic method and vaccine using a composition comprising truncated r47 protein and truncated r56 protein; reducing HIV viral loads |
| 02/21/2008 | US20080044502 Use of an aqueous or hydroalcoholic extract of bauhinia for the preparation of a composition |
| 02/21/2008 | US20080044499 Sleep Improvement Composition |
| 02/21/2008 | US20080044498 Therapeutic or prophylactic agent, and method of treating or preventing a disease |
| 02/21/2008 | US20080044486 Controlled Food Effect Composition |
| 02/21/2008 | US20080044482 Orally administrable opioid formulations having extended duration of effect |
| 02/21/2008 | US20080044468 Processes For The Preparation Of Oral Dosage Formulations Of Modafinil |
| 02/21/2008 | US20080044464 Liposome loading with metal ions |
| 02/21/2008 | US20080044457 Antitumor agents; time-release agents; pulverization |
| 02/21/2008 | US20080044432 Mammalian receptor proteins; related reagents and methods |
| 02/21/2008 | US20080044428 Glycosylphosphatidylinositol Glycan Signalling Via Integrins Functioning as Glycan Specific Receptors |
| 02/21/2008 | US20080044422 CNGH0010 Specific Polynucleotides, Polypeptides, Antibodies, Compositions, Methods and Uses |
| 02/21/2008 | US20080044420 Anti-IL-13 antibodies, compositions, methods and uses |
| 02/21/2008 | US20080044418 Tumor Antigens and Uses Thereof |